SCHEMBL14648366

SCHEMBL14648366

CCC1CC(C(C)C)=NN1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21610399 0.72 — —
SCHEMBL18867154 0.67 — —
SCHEMBL24054565 0.64 — —
SCHEMBL14648368 0.61 MIF (0.31) —
SCHEMBL10037199 0.59 — —
SCHEMBL18634492 0.59 — —
SCHEMBL13313042 0.58 — —
SCHEMBL21323164 0.56 — —
SCHEMBL12240416 0.54 — —
SCHEMBL8960369 0.54 ALDH1A1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150297596-A1 ISOXAZOLINES AS THERAPEUTIC AGENTS ABBVIE INC. (US) 2015-10-22 — — US disclosed
US-9029409-B2 Isoxazolines as therapeutic agents ABBVIE INC. (US) 2015-05-12 — — US disclosed
US-20130023526-A1 Isoxazolines as Therapeutic Agents ABBOTT LABORATORIES (US) 2013-01-24 — — US disclosed
Send feedback